Capsule colonoscopy option increases uptake of colorectal cancer screening

ISRCTN ISRCTN59303311
DOI https://doi.org/10.1186/ISRCTN59303311
Secondary identifying numbers CRCS Uptake study 1
Submission date
21/06/2011
Registration date
28/07/2011
Last edited
12/06/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims:
Colorectal cancer screening is used to detect cancer at an early stage, before symptoms start to appear. It is done because treating the disease is more successful if its caught at an early stage. Endoscopy is an effective method of exploring the bowel for signs of cancer. A thin, flexible tube with a tiny camera attached is placed into the bowel. The medical team is then able to see the inside of the bowel though images sent to a television screen. Despite its success, many people who would otherwise benefit from the procedure (i.e. people over the age of 55) are reluctant to take part due, in part, to it being thought of as unpleasant. Capsule endoscopy is a new method which is painless and involves swallowing a small pill-like video camera which travels through the bowel and takes images. It is thought that capsule endoscopy might encourage more people to undergo colorectal cancer screening. This study aims to explore whether inviting people to undertake endoscopic screening for colorectal cancer and offering the new capsule endoscopy will persuade more people to go for screening compared to those offered conventional endoscopy.

Who can participate?
People over the age of 55 who are insured with BKK 24 in the area of Rintein/Lower Saxonia (Germany)

What does the study involve?
The participants receive an invitation letter for colorectal cancer screening by either conventional or capsule endoscopy. The participants then respond if they want to undergo the procedure.

What are the possible benefits and risks of participating?
The study per se only measures uptake. The risks of the endoscopic procedures are well known and will be communicated in the informed consent

Where is the study run from?
Rinteln, Lower Saxonia, Germany

When is study starting and how long is it expected to run for?
March 2009 to July 2011

Who is funding the study?
Given Imaging Ltd (Germany)

Who is the main contact?
Prof. Dr. Thomas Rösch
t.roesch@uke.de

Contact information

Prof Thomas Rösch
Scientific

Department of Interdisciplinary Endoscopy
University Hospital Hamburg Eppendorf
Martinistr. 52
Hamburg
20246
Germany

Email t.roesch@uke.de

Study information

Study designProspective single arm study
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleCapsule colonoscopy option increases uptake of colorectal cancer screening: a prospective regional study in Germany
Study objectivesCapsule colonoscopy increases uptake as compared to conventional colonoscopy when offered to persons eligible for colorectal cancer screening
Ethics approval(s)International Medical & Dental Ethics Commission (IMDEC) GmbH Ethical Committee, Freiburg approved on 31st March 2009
Health condition(s) or problem(s) studiedColorectal cancer screening
Intervention2150 participants receive an invitation letter for colorectal cancer screening by either conventional or capsule endoscopy. The pros and cons of each are briefly described and can be further discussed with four gastroenterologists who are named in the letter. Follow-up is 1-2 weeks after capsule and/or conventional colonoscopy.

The practical part of the study took part in 2009. It took until the end of last year to collect all the data from private practice physicians (time constraints for audits).
Intervention typeOther
Primary outcome measureUptake of capsule and conventional endoscopy after invitation (measured whenever patients react to the letters, usually within a few weeks) as compared to spontaneous uptake in the same area in the preceeding years
Secondary outcome measures1. Adenoma yield in both groups, namely the capsule group including those participants with subsequent colonoscopy, and the group with capsule colonoscopy only
2. Rate of capsule examinations with sufficient bowel preparation (grading was done on a 4-point scale in accordance with previous studies
3. Adverse events and complications in both arms of the study
4. Patient opinion and acceptability according to the questionnaires

Measured during or after (2 weeks) performance of either conventional and/or capsule endoscopy
Overall study start date01/03/2009
Completion date31/07/2011

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants2150
Key inclusion criteria1. Persons over 55 years of age eligible for screening insured with BKK 24 in the area of Rinteln/Lower Saxonia (Germany) are invited by a letter sent out from BKK 24 medical insurance during 2009 to participate in screening using either capsule or conventional colonoscopy.
2. Interested persons are informed by four gastroenterologists and one of the tests will then be performed at screnees choice
Key exclusion criteria1. Symptomatic persons
2. Persons having undergone screening colonoscopy
Date of first enrolment01/03/2009
Date of final enrolment31/07/2011

Locations

Countries of recruitment

  • Germany

Study participating centre

Department of Interdisciplinary Endoscopy
Hamburg
20246
Germany

Sponsor information

Given Imaging Ltd. (Germany)
Industry

c/o Manfred Gehrtz
Borsteler Chaussee 47
Hamburg
22453
Germany

Email Manfred.Gehrtz@givenimaging.com
ROR logo "ROR" https://ror.org/00fdh5j55

Funders

Funder type

Industry

Given Imaging Ltd. (Germany)

No information available

BKK 24 Medical Insurance Company (Germany)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan